Bradford Health Services, a US provider of addiction treatment programs, has acquired Cornerstone of Recovery, a Tennessee-based substance use disorder treatment provider. Bradford Health Services is backed by Centre Partners, a middle-market private equity firm focused on the consumer and healthcare sectors.
Elvie, a global health and lifestyle brand developing products for women, has extended its Series C funding with a further GBP12.7 million (USD17.5 million) investment. This investment – an extension to the initial Series C funding announced in July 2021 – takes Elvie’s total Series C to GBP70 million (USD97
ILC Therapeutics, a UK-based biotechnology company and pioneer in the discovery and development of a ground-breaking new class of interferon drugs, has completed a GBP3.5 million pre-IPO funding round. Investors include Los Angeles-based lawyer and investor, Robert Kopple; St Andrews-based Eos Angel Investment Syndicate; Scottish Enterprise; ILCT management. Chairman Peter
contextflow, a provider of artificial intelligence for medical image analysis, has raised EUR6.7 million in a Series A funding round. A second closing included an additional EUR2 million from new co-investor Peak Pride Management GmbH, HPH (Hans Peter Haselsteiner) Start-up Unit and current investor APEX Ventures with its “APEX Best
Global Healthcare Opportunities, or GHO Capital Partners, a European specialist investor in global healthcare, and the founding partners of ClearView Healthcare Partners, announce a majority recapitalisation of ClearView Healthcare Partners (ClearView), a life sciences strategic consultancy supporting Pharma and Biotech sponsors globally. Headquartered in Boston and with offices in New
GED Capital, a private equity group focused on the Iberian lower mid-market segment, has acquired 100 per cent of the shares in health service providers High Research, Interactive Communication Projects, (3.Ways), and BCN Science from their respective founders and management teams.
Arma Partners has acted as exclusive financial advisor to Montagu, a European private equity firm, on the sale of Servelec, a software provider to healthcare and local authorities based in the UK, to The Access Group. Headquartered in Sheffield, Servelec develops mission-critical software solutions, with an extensive product portfolio including
quip, an oral healthcare company with over 7.5 million users, has raised USD100 million in growth funding from Cowen Sustainable Investments (CSI) an environmental sustainability focused growth investment strategy. On the heels of reaching profitability, expanding into new oral care verticals, and launching its first professional services, CSI recognised quip’s
3i Group has partnered with Professor Dr Hanns-Christian Mahler to create ten23 health, a pure-play, patient-centric and sustainable biologics drug product contract development and manufacturing organisation (CDMO) focused on helping innovative biotech and pharma customers develop and commercialise injectable biopharmaceutical drugs. Mahler, CEO of ten23 health, previously built a highly
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, has closed a Series C round of financing, raising EUR50 million from new and existing international investors. Cathay Health, affiliated to global investment firm Cathay Capital, led new investors and joined other institutional and individual backers while existing
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
